首页> 美国卫生研究院文献>Oxford Open >2737. Comparison of Antibody Responses to Vaccination with a Pure Hemagglutinin Influenza Vaccine (rHA) and Licensed Subvirion Influenza Vaccine Made in Eggs or Cell Culture in Adults 60 Years and Older
【2h】

2737. Comparison of Antibody Responses to Vaccination with a Pure Hemagglutinin Influenza Vaccine (rHA) and Licensed Subvirion Influenza Vaccine Made in Eggs or Cell Culture in Adults 60 Years and Older

机译:2737.比较使用纯血凝素流感疫苗(rHA)和60岁及以上成年人的鸡蛋或细胞培养制成的亚病毒株许可疫苗对抗体的反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundInfluenza is associated with increased mortality and morbidity for older adults. High-dose egg grown trivalent inactivated influenza vaccine (Fluzone HD) is safe and provides superior immune responses in older adults compared with standard dose (SD). Recently, two new vaccines have been licensed in the United States: cell cultured inactivated vaccine FluCelVax and baculovirus-expressed pure hemagglutinin (HA) vaccine FluBlok. Data from one study demonstrated higher efficacy with FluBlok than SD Fluzone in older adults. There is no data however comparing HD Fluzone to FluBlok and FluCelVax has not been studied at all. The purpose of this study was to assess hemagglutinin inhibition (HAI) antibody responses to vaccination with three vaccines in adults ≥ 60 years.
机译:背景流感与老年人死亡率和发病率增加有关。与标准剂量(SD)相比,大剂量卵生长的三价灭活流感疫苗(Fluzone HD)是安全的,并且在老年人中具有出色的免疫反应。最近,两种新疫苗已在美国获得许可:细胞培养的灭活疫苗FluCelVax和杆状病毒表达的纯血凝素(HA)疫苗FluBlok。一项研究的数据表明,在老年人中,使用FluBlok的疗效要优于使用SD Fluzone。没有数据,但是根本没有研究将HD Fluzone与FluBlok和FluCelVax进行比较。这项研究的目的是评估60岁以上成年人中三种疫苗的血凝素抑制(HAI)抗体对疫苗接种的反应。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号